What's breaking now, across thousands of outlets.
Researchers at Memorial Sloan Kettering Cancer Center (MSK) and their colleagues have discovered that a type of rogue DNA found in aggressive cancers has a hidden structural weakness—and that blocking a single repair protein can cause it to fall apart, suggesting a new therapeutic opportunity.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.
The study showed the number of adults 55 and older seeking care doubled in eight years from about 7,100 in 2017 to more than 15,000 in 2025.
The study showed the number of adults 55 and older seeking care doubled in eight years from about 7,100 in 2017 to more than 15,000 in 2025.
[UN News] Ahead of the 40th anniversary of the groundbreaking Declaration on the Right to Development this December, world leaders gathered at a High-Level Week meeting on Wednesday to map progress…
The collaboration pairs the Genialis Supermodel with Inventia Life Science’s RASTRUM 3D cell model platform to test therapeutic hypotheses in models that mirror the tumor biology of specific patient…
A slow-release liposome system delivered local anesthesia for weeks in rats, potentially enabling longer-lasting nerve blocks and new approaches to pain management.
(MedPage Today) -- Nearly one-third of people who tested positive for the bacteria that cause Lyme disease also tested positive for other tick-borne pathogens, according to a retrospective cohort…
